"","Pathway","No. of In-group Genes in Pathway","Total No. of Genes in Pathway","Adjusted P-value","In-group Genes in Pathway"
"1","Extracellular matrix organization",120,297,0,"ADAM12, ADAM19, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS3, ADAMTS8, ADAMTS9, BGN, BMP10, BMP2, BMP4, CAPN13, CAPN9, CD44, CEACAM6, COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL21A1, COL26A1, COL27A1, COL28A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, COLGALT2, CTSV, DCN, EFEMP1, EFEMP2, EMILIN2, FBN1, FBN2, FBN3, FGF2, FGG, FN1, HSPG2, ICAM1, ICAM2, ICAM5, ITGA1, ITGA3, ITGA4, ITGA5, ITGA6, ITGB1, ITGB2, ITGB3, ITGB4, ITGB8, KLK7, KLKB1, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, LOX, LOXL1, LOXL2, LOXL4, LRP4, LTBP2, LTBP3, MATN3, MFAP2, MFAP5, MMP14, MMP2, MMP24, MMP9, MUSK, NID1, NTN4, P3H1, P3H2, P3H3, PCOLCE2, PRKCA, SDC4, SERPINE1, SH3PXD2A, SPARC, SPOCK3, SPP1, TGFB1, TGFB2, TGFB3, THBS1, TIMP1, TIMP2, TLL1, TNR, VCAN, VTN"
"2","Collagen formation",48,90,0,"ADAMTS14, ADAMTS3, COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL21A1, COL26A1, COL27A1, COL28A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, COLGALT2, CTSV, ITGA6, ITGB4, LAMA3, LAMB3, LAMC2, LOX, LOXL1, LOXL2, LOXL4, MMP9, P3H1, P3H2, P3H3, PCOLCE2, TLL1"
"3","Degradation of the extracellular matrix",57,138,0,"ADAMTS16, ADAMTS18, ADAMTS8, ADAMTS9, CAPN13, CAPN9, CD44, COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL26A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, CTSV, DCN, FBN1, FBN2, FBN3, FN1, HSPG2, KLK7, KLKB1, LAMA3, LAMB1, LAMB3, LAMC1, LAMC2, MMP14, MMP2, MMP24, MMP9, NID1, SPOCK3, SPP1, TIMP1, TIMP2, TLL1"
"4","Collagen biosynthesis and modifying enzymes",37,67,0,"ADAMTS14, ADAMTS3, COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL21A1, COL26A1, COL27A1, COL28A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, COLGALT2, P3H1, P3H2, P3H3, PCOLCE2, TLL1"
"5","Assembly of collagen fibrils and other multimeric structures",35,61,0,"COL11A1, COL12A1, COL14A1, COL15A1, COL17A1, COL18A1, COL1A2, COL27A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, CTSV, ITGA6, ITGB4, LAMA3, LAMB3, LAMC2, LOX, LOXL1, LOXL2, LOXL4, MMP9, TLL1"
"6","Collagen chain trimerization",29,44,0,"COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL21A1, COL26A1, COL27A1, COL28A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3"
"7","Laminin interactions",23,30,0,"COL18A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, HSPG2, ITGA1, ITGA3, ITGA6, ITGB1, ITGB4, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, NID1"
"8","Non-integrin membrane-ECM interactions",33,59,0,"COL11A1, COL1A2, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, FGF2, FN1, HSPG2, ITGA6, ITGB1, ITGB3, ITGB4, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, NTN4, PRKCA, SDC4, TGFB1, THBS1, VTN"
"9","Integrin cell surface interactions",39,83,0,"CD44, COL13A1, COL16A1, COL18A1, COL1A2, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, FBN1, FGG, FN1, HSPG2, ICAM1, ICAM2, ICAM5, ITGA1, ITGA3, ITGA4, ITGA5, ITGA6, ITGB1, ITGB2, ITGB3, ITGB8, SPP1, THBS1, VTN"
"10","ECM proteoglycans",37,76,0,"BGN, COL1A2, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, DCN, FN1, HSPG2, ITGB1, ITGB3, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMC1, LRP4, MATN3, MUSK, SERPINE1, SPARC, TGFB1, TGFB2, TGFB3, TNR, VCAN, VTN"
"11","Elastic fibre formation",26,45,0,"BMP10, BMP2, BMP4, EFEMP1, EFEMP2, EMILIN2, FBN1, FBN2, FBN3, FN1, ITGA5, ITGB1, ITGB3, ITGB8, LOX, LOXL1, LOXL2, LOXL4, LTBP2, LTBP3, MFAP2, MFAP5, TGFB1, TGFB2, TGFB3, VTN"
"12","GPCR ligand binding",104,448,0,"ADCYAP1, ADGRE1, ADGRE5, ADM, ADORA2B, ADRA1B, ADRA2C, ADRB2, AGTR1, ANXA1, AVPR1A, AVPR2, C3, C5AR2, CALCRL, CASR, CCL17, CCL20, CCR7, CCRL2, CGA, CMKLR1, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, CYSLTR1, DRD1, EDN1, EDNRB, F2R, F2RL1, F2RL3, FFAR2, FPR1, FZD2, FZD6, FZD7, GABBR1, GAL, GLP2R, GNG10, GNG11, GNG2, GNGT2, GPR17, GRM3, GRM4, GRM8, GRPR, HCAR2, HCAR3, HRH1, HRH3, HTR1D, HTR2C, HTR4, KISS1, LPAR1, LPAR3, LPAR5, MC4R, MTNR1A, NMU, NPFFR1, NPY1R, NPY4R, NPY5R, NTS, P2RY1, P2RY10, P2RY2, PLPPR1, PLPPR3, PLPPR4, PTGER3, PTGFR, PTH1R, QRFPR, RAMP1, RAMP2, RAMP3, S1PR1, SMO, TAS2R46, TBXA2R, TRH, UTS2, UTS2B, VIPR1, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT6, WNT7A, XCL1, XK"
"13","MET activates PTK2 signaling",20,30,0,"COL11A1, COL1A2, COL27A1, COL3A1, COL5A1, COL5A2, FN1, ITGA3, ITGB1, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, MET, SRC"
"14","Collagen degradation",29,62,0,"COL11A1, COL12A1, COL13A1, COL14A1, COL15A1, COL16A1, COL17A1, COL18A1, COL19A1, COL1A2, COL26A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, COL5A1, COL5A2, COL6A1, COL6A2, COL8A1, COL8A2, COL9A1, COL9A3, MMP14, MMP2, MMP9"
"15","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)",43,125,0,"AMBN, AMTN, APOA1, APOE, APOL1, BMP4, BPIFB2, C3, CCN1, CDH2, CHRDL1, CSF1, ENAM, EVA1A, FAM20A, FBN1, FGG, FN1, FSTL1, FSTL3, GAS6, IGFBP5, IGFBP6, IGFBP7, IL6, KLK1, KLK13, LAMB1, LAMC1, LGALS1, MATN3, MELTF, MFGE8, MGAT4A, MMP2, MSLN, NOTUM, PAPPA, PCSK9, SCG2, SPP1, TIMP1, VCAN"
"16","Cell surface interactions at the vascular wall",45,136,0,"ANGPT1, CAV1, CD177, CD44, CD74, CEACAM5, CEACAM6, COL1A2, FN1, FYN, GAS6, ITGA3, ITGA4, ITGA5, ITGA6, ITGB1, ITGB2, ITGB3, L1CAM, LCK, LYN, OLR1, PROCR, PROS1, PSG1, PSG11, PSG2, PSG3, PSG4, PSG5, PSG6, PSG7, PSG8, PSG9, SDC4, SELP, SELPLG, SLC16A1, SLC16A3, SLC7A10, SLC7A7, SRC, TEK, TGFB1, TNFRSF10D"
"17","Molecules associated with elastic fibres",21,38,0,"BMP10, BMP2, BMP4, EFEMP1, EFEMP2, EMILIN2, FBN1, FBN2, FBN3, FN1, ITGB1, ITGB3, ITGB8, LTBP2, LTBP3, MFAP2, MFAP5, TGFB1, TGFB2, TGFB3, VTN"
"18","Hemostasis",131,606,0,"ABCC4, ADRA2C, ANGPT1, ANXA2, APBB1IP, APOA1, ARRB1, ATP2A3, CAV1, CD109, CD177, CD44, CD74, CEACAM5, CEACAM6, CLEC3B, COL1A2, DGKA, DGKB, DGKG, EHD2, F2R, F2RL3, F3, F7, FGG, FLNA, FN1, FYN, GAS6, GATA3, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, GUCY1A2, IFNA1, ISLR, ITGA1, ITGA3, ITGA4, ITGA5, ITGA6, ITGB1, ITGB2, ITGB3, KIF1A, KIF26A, KIF26B, KIF3C, KIF5A, KIFC2, KLC3, KLKB1, L1CAM, LCK, LYN, MYB, NFE2, OLR1, P2RX2, P2RX5, P2RX6, P2RY1, PDE1A, PDPN, PIK3R3, PIK3R5, PLA2G4A, PLAT, PLAU, PLAUR, PRCP, PRKCA, PRKCH, PRKCQ, PRKG2, PROCR, PROS1, PSG1, PSG11, PSG2, PSG3, PSG4, PSG5, PSG6, PSG7, PSG8, PSG9, RAB27B, RAC2, SDC4, SELENOP, SELP, SELPLG, SERPINA3, SERPINB2, SERPINE1, SERPINE2, SERPINF2, SERPING1, SLC16A1, SLC16A3, SLC7A10, SLC7A7, SLC8A1, SPARC, SRC, SRGN, TBXA2R, TEK, TFPI, TGFB1, TGFB2, TGFB3, THBS1, TIMP1, TIMP3, TNFRSF10D, TRPC3, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, VAV1, VAV3, ZFPM2"
"19","Post-translational protein phosphorylation",38,108,0,"AMBN, AMTN, APOA1, APOE, APOL1, BMP4, BPIFB2, C3, CCN1, CDH2, CHRDL1, CSF1, ENAM, EVA1A, FAM20A, FBN1, FGG, FN1, FSTL1, FSTL3, GAS6, IGFBP5, IGFBP7, IL6, LAMB1, LAMC1, LGALS1, MATN3, MELTF, MFGE8, MGAT4A, MSLN, NOTUM, PCSK9, SCG2, SPP1, TIMP1, VCAN"
"20","MET promotes cell motility",21,41,0,"COL11A1, COL1A2, COL27A1, COL3A1, COL5A1, COL5A2, FN1, ITGA3, ITGB1, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, MET, SRC, TNS3"
"21","Class A 1 (Rhodopsin-like receptors)",72,317,0,"ADORA2B, ADRA1B, ADRA2C, ADRB2, AGTR1, ANXA1, AVPR1A, AVPR2, C3, C5AR2, CCL17, CCL20, CCR7, CCRL2, CGA, CMKLR1, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, CYSLTR1, DRD1, EDN1, EDNRB, F2R, F2RL1, F2RL3, FFAR2, FPR1, GAL, GPR17, GRPR, HCAR2, HCAR3, HRH1, HRH3, HTR1D, HTR2C, HTR4, KISS1, LPAR1, LPAR3, LPAR5, MC4R, MTNR1A, NMU, NPFFR1, NPY1R, NPY4R, NPY5R, NTS, P2RY1, P2RY10, P2RY2, PLPPR1, PLPPR3, PLPPR4, PTGER3, PTGFR, QRFPR, S1PR1, TBXA2R, TRH, UTS2, UTS2B, XCL1, XK"
"22","NCAM1 interactions",20,42,0,"CACNA1D, CACNA1H, CACNA1I, CACNB1, CACNB4, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, GDNF, GFRA1, PRNP"
"23","Crosslinking of collagen fibrils",12,18,1e-04,"COL1A2, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, LOX, LOXL1, LOXL2, LOXL4, TLL1"
"24","Anchoring fibril formation",11,15,1e-04,"COL1A2, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL4A6, LAMA3, LAMB3, LAMC2, TLL1"
"25","G alpha (q) signalling events",54,214,1e-04,"ADRA1B, AGTR1, ANXA1, ARHGEF25, AVPR1A, CASR, CYSLTR1, DGKA, DGKB, DGKG, EDN1, EDNRB, EGFR, F2R, F2RL1, F2RL3, FFAR2, GAST, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, GPR17, GRPR, HBEGF, HRH1, HTR2C, KALRN, KISS1, LPAR1, LPAR3, LPAR5, NMU, NPFFR1, NTS, P2RY1, P2RY10, P2RY2, PIK3R3, PRKCA, PRKCH, PRKCQ, PTGFR, QRFPR, RGS16, RGS4, TBXA2R, TRH, TRPC3, UTS2, UTS2B, XCL1"
"26","Muscle contraction",52,196,1e-04,"ABCC9, ACTA2, ANXA1, ANXA2, ATP2A3, CACNB1, CACNG4, CACNG6, CACNG7, CALD1, CAMK2A, CAV3, DYSF, FGF13, FGF14, FKBP1B, FXYD1, FXYD3, FXYD6, FXYD7, GUCY1A2, ITGA1, KCND3, KCNE3, KCNE5, KCNIP1, KCNIP3, KCNJ11, KCNJ2, KCNJ4, LMOD1, MYL2, MYL3, MYL4, MYL9, MYLK, NPR1, NPR2, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SLC8A1, SORBS3, TMOD2, TNNC1, TNNT1, TPM2, TRPC1, VIM"
"27","Syndecan interactions",15,27,1e-04,"COL1A2, COL3A1, COL5A1, COL5A2, FGF2, FN1, ITGA6, ITGB1, ITGB3, ITGB4, PRKCA, SDC4, TGFB1, THBS1, VTN"
"28","Defective B3GALTL causes Peters-plus syndrome (PpS)",17,36,3e-04,"ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, THBS1, THSD7A"
"29","Interleukin-10 signaling",17,41,3e-04,"CCL20, CSF1, CSF2, CXCL1, CXCL2, CXCL8, FPR1, ICAM1, IL12B, IL18, IL1A, IL1R2, IL6, LIF, PTGS2, TIMP1, TNFRSF1B"
"30","O-glycosylation of TSR domain-containing proteins",17,37,4e-04,"ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, THBS1, THSD7A"
"31","Cell junction organization",29,90,5e-04,"CDH11, CDH13, CDH2, CDH3, CDH6, CDH7, CLDN1, CLDN10, CLDN11, CLDN16, CLDN18, CLDN3, CLDN6, CLDN8, COL17A1, FBLIM1, FLNA, FLNC, ITGA6, ITGB1, ITGB4, KRT14, LAMA3, LAMB3, LAMC2, LIMS2, NECTIN3, NECTIN4, PVR"
"32","O-linked glycosylation",33,109,9e-04,"A4GNT, ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, B3GNT3, B3GNT5, B3GNT7, CHST4, GALNT5, GALNTL6, LARGE1, MUC13, MUC16, MUC19, MUC5B, MUCL1, ST6GALNAC2, ST6GALNAC3, ST6GALNAC4, THBS1, THSD7A"
"33","Platelet activation, signaling and aggregation",59,258,0.0019,"ABCC4, ADRA2C, APBB1IP, APOA1, ARRB1, CD109, CLEC3B, COL1A2, DGKA, DGKB, DGKG, F2R, F2RL3, FGG, FLNA, FN1, FYN, GAS6, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, ISLR, ITGB3, LCK, LYN, P2RY1, PDPN, PIK3R3, PIK3R5, PLA2G4A, PRKCA, PRKCH, PRKCQ, PROS1, RAB27B, RAC2, SELENOP, SELP, SERPINA3, SERPINE1, SERPINF2, SERPING1, SPARC, SRC, SRGN, TBXA2R, TGFB1, TGFB2, TGFB3, THBS1, TIMP1, TIMP3, TRPC3, TUBA4A, VAV1, VAV3"
"34","Diseases associated with O-glycosylation of proteins",23,67,0.0024,"ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, LARGE1, MUC13, MUC16, MUC19, MUC5B, MUCL1, THBS1, THSD7A"
"35","NCAM signaling for neurite out-growth",22,63,0.0027,"CACNA1D, CACNA1H, CACNA1I, CACNB1, CACNB4, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, FYN, GDNF, GFRA1, PRNP, SRC"
"36","Dissolution of Fibrin Clot",8,13,0.0044,"ANXA2, PLAT, PLAU, PLAUR, SERPINB2, SERPINE1, SERPINE2, SERPINF2"
"37","Signal Transduction",415,2695,0.0049,"ABCG1, ACTA2, ACVRL1, ADAM12, ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADGRE1, ADGRE5, ADM, ADORA2B, ADRA1B, ADRA2C, ADRB2, AGTR1, AKT3, ANGPT1, ANXA1, APBB1IP, APOA1, APOC1, APOC4, APOE, AR, ARAP3, ARHGAP18, ARHGAP22, ARHGAP29, ARHGAP31, ARHGAP36, ARHGAP42, ARHGEF25, ARHGEF35, ARHGEF38, ARHGEF4, ARRB1, ATP2A3, ATP6V0D2, ATP6V0E2, AVPR1A, AVPR2, AWAT2, AXIN2, AXL, BCL2, BDNF, BEX3, BIRC3, BMP10, BMP2, C3, C5AR2, CALCRL, CAMK2A, CAMK4, CASR, CAV1, CAV2, CCL17, CCL20, CCR7, CCRL2, CDC14B, CDC42EP3, CFTR, CGA, CHRDL1, CITED1, CMKLR1, CNKSR2, COL11A1, COL1A2, COL27A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, CRABP1, CSF2, CSF2RA, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, CYP26A1, CYSLTR1, DACT1, DEPDC7, DGKA, DGKB, DGKG, DIAPH2, DKK1, DLC1, DRD1, DUSP4, DUSP9, DYNC1I1, DYNC2H1, DZIP1, EDN1, EDNRB, EGFR, ELF3, ESR1, EVC2, EVL, F2R, F2RL1, F2RL3, F3, FABP5, FFAR2, FGF1, FGF2, FGF20, FGF5, FGFBP1, FGFR2, FGG, FLNA, FLRT2, FLT4, FMNL2, FN1, FOSL1, FOXA1, FPR1, FRAT1, FST, FSTL1, FSTL3, FYN, FZD2, FZD6, FZD7, GABBR1, GABRA1, GABRG2, GAL, GAST, GATA3, GDNF, GFRA1, GLI2, GLI3, GLP2R, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR161, GPR17, GPR176, GPR20, GPSM3, GREB1, GRIN1, GRM3, GRM4, GRM8, GRPR, GUCY2D, H2AJ, HBEGF, HCAR2, HCAR3, HDAC9, HECW1, HEY2, HEYL, HHIP, HRH1, HRH3, HSPB1, HSPG2, HTR1D, HTR2C, HTR4, ID2, IFT57, IL1RAP, IL33, IL6, INHBA, INHBB, IQGAP2, ITGA3, ITGB1, ITGB3, JAG1, KALRN, KANK1, KIF5A, KIF7, KISS1, KL, KLC3, KSR1, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, LCK, LEPR, LGR5, LPAR1, LPAR3, LPAR5, LRP1, LRP12, LRP2, LRRK2, LYN, MAML2, MC4R, MCF2, MDK, MECOM, MET, MFNG, MMP2, MMP9, MRAS, MST1R, MTNR1A, MYB, MYL9, MYLK, NCF2, NEURL1, NEURL1B, NGF, NGFR, NMU, NOG, NOTUM, NOXA1, NPFFR1, NPY1R, NPY4R, NPY5R, NR5A2, NRG1, NRG3, NRP1, NRP2, NTF3, NTF4, NTS, OR10A3, OR1F1, OR1Q1, OR2AG2, OR56A3, OR5AU1, OR7D2, P2RY1, P2RY10, P2RY2, PDE1A, PDE1C, PDE3A, PDE4A, PDE6B, PDGFC, PDGFRB, PGF, PGR, PIK3AP1, PIK3CD, PIK3R3, PIK3R5, PIP5K1B, PLA2G4A, PLAT, PLB1, PLEKHG2, PLPPR1, PLPPR3, PLPPR4, PLTP, PLXND1, PPP1R14A, PREX1, PREX2, PRICKLE1, PRKCA, PRKCH, PRKCQ, PRKG2, PSMB8, PTGER3, PTGFR, PTH1R, PYGO1, QRFPR, RAC2, RAG1, RAMP1, RAMP2, RAMP3, RASAL2, RASGRP3, RBP1, RBP4, REEP2, RET, RGS16, RGS20, RGS4, RGS9, RHOH, RHOJ, RHOU, RHOV, RHPN1, ROR1, ROR2, RRAD, RSPO3, RTP3, RXRG, S100A8, S1PR1, SDC4, SDR16C5, SDR9C7, SERPINE1, SFRP1, SGK1, SH2D2A, SH3KBP1, SMAD9, SMO, SMURF2, SNAI2, SOST, SOX2, SOX3, SOX7, SPARC, SPP1, SPRY2, SRC, SRMS, STARD8, STRA6, SYDE1, TAS2R46, TBXA2R, TCF7, TEK, TFF1, TFF3, TGFA, TGFB1, TGFBR2, THBS1, TIAM2, TLE4, TNFAIP3, TNFRSF10D, TNFSF10, TNS3, TRAT1, TRH, TRPC3, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, UTS2, UTS2B, VANGL2, VAV1, VAV3, VIPR1, WIF1, WLS, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT5B, WNT6, WNT7A, XCL1, XK"
"38","Constitutive Signaling by Aberrant PI3K in Cancer",23,75,0.0063,"EGFR, ESR1, FGF1, FGF2, FGF20, FGF5, FGFR2, FYN, HBEGF, KL, LCK, MET, NRG1, NRG3, PDGFRB, PIK3AP1, PIK3CD, PIK3R3, RAC2, SRC, TGFA, TRAT1, VAV1"
"39","Class B 2 (Secretin family receptors)",26,94,0.0064,"ADCYAP1, ADGRE1, ADGRE5, ADM, CALCRL, FZD2, FZD6, FZD7, GLP2R, GNG10, GNG11, GNG2, GNGT2, PTH1R, RAMP1, RAMP2, RAMP3, SMO, VIPR1, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT6, WNT7A"
"40","Cell-Cell communication",34,128,0.0071,"CDH11, CDH13, CDH2, CDH3, CDH6, CDH7, CLDN1, CLDN10, CLDN11, CLDN16, CLDN18, CLDN3, CLDN6, CLDN8, COL17A1, FBLIM1, FLNA, FLNC, FYN, ITGA6, ITGB1, ITGB4, KIRREL1, KIRREL2, KRT14, LAMA3, LAMB3, LAMC2, LIMS2, NECTIN3, NECTIN4, PVR, SIRPB1, SRC"
"41","Peptide ligand-binding receptors",41,187,0.0071,"AGTR1, ANXA1, AVPR1A, AVPR2, C3, C5AR2, CCL17, CCL20, CCR7, CCRL2, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, EDN1, EDNRB, F2R, F2RL1, F2RL3, FPR1, GAL, GRPR, KISS1, MC4R, NMU, NPFFR1, NPY1R, NPY4R, NPY5R, NTS, QRFPR, TRH, UTS2, UTS2B, XCL1, XK"
"42","Interleukin-4 and Interleukin-13 signaling",29,108,0.0077,"ANXA1, BCL2, COL1A2, CXCL8, FGF2, FN1, FSCN1, GATA3, ICAM1, IL12B, IL18, IL1A, IL6, ITGB1, ITGB2, LBP, LIF, MMP2, MMP9, PTGS2, RHOU, RORC, S1PR1, SOX2, TGFB1, TIMP1, TNFRSF1B, VIM, ZEB1"
"43","L1CAM interactions",32,117,0.0077,"ANK2, CNTNAP1, EGFR, EPHB2, GAP43, ITGA1, ITGA5, ITGB1, ITGB3, KCNQ3, L1CAM, LAMA1, LAMB1, LAMC1, MSN, NFASC, NRP1, NRP2, RPS6KA6, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SRC, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"44","Gap junction assembly",13,34,0.0104,"GJA1, GJA3, GJB2, GJB3, GJB6, GJC1, GJC2, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"45","Type I hemidesmosome assembly",7,11,0.0126,"COL17A1, ITGA6, ITGB4, KRT14, LAMA3, LAMB3, LAMC2"
"46","Neuronal System",83,407,0.0127,"ABAT, ABCC9, ADCY1, ADCY2, ADCY5, ADCY7, BCHE, CACNA2D1, CACNB1, CACNB4, CACNG4, CAMK2A, CAMK4, CHAT, CPLX1, DLGAP3, EPB41L2, GABBR1, GABRA1, GABRA3, GABRG2, GAD1, GJC1, GLRA3, GNG10, GNG11, GNG2, GNGT2, GRIK3, GRIK4, GRIN1, IL1RAP, IL1RAPL1, KCNA7, KCNB2, KCNC4, KCND3, KCNG1, KCNG4, KCNH3, KCNH5, KCNJ11, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4, KCNN2, KCNN4, KCNQ3, KCNQ5, KCNS1, KCNS3, KIF17, LIN7A, LRFN2, MAPT, NAAA, NCALD, NLGN1, NRG1, NRXN3, PPFIBP2, PRKCA, RAB3A, RIMS1, RPS6KA6, SLC1A1, SLC1A3, SLC6A11, SLITRK4, SLITRK5, SLITRK6, SRC, SYT12, SYT7, SYT9, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"47","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors",8,15,0.0133,"CGA, CGB5, CGB8, EGFR, ESR1, TFAP2B, TFAP2C, TGFA"
"48","TRP channels",12,28,0.0133,"MCOLN2, MCOLN3, RIPK3, TRPC1, TRPC3, TRPC4, TRPM3, TRPM6, TRPV3, TRPV4, TRPV5, TRPV6"
"49","Antagonism of Activin by Follistatin",4,4,0.0149,"FST, FSTL3, INHBA, INHBB"
"50","Phase 0 - rapid depolarisation",13,34,0.0204,"CACNB1, CACNG4, CACNG6, CACNG7, CAMK2A, FGF13, FGF14, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A"
"51","Cardiac conduction",32,128,0.0223,"ABCC9, ATP2A3, CACNB1, CACNG4, CACNG6, CACNG7, CAMK2A, FGF13, FGF14, FKBP1B, FXYD1, FXYD3, FXYD6, FXYD7, KCND3, KCNE3, KCNE5, KCNIP1, KCNIP3, KCNJ11, KCNJ2, KCNJ4, NPR1, NPR2, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SLC8A1, TRPC1"
"52","Post-translational modification- synthesis of GPI-anchored proteins",23,88,0.0244,"ALPG, ALPI, CD109, CEACAM5, CEACAM7, CNTN3, CNTN5, CPM, GP2, LY6G6C, LY6H, LYPD5, MELTF, MSLN, NEGR1, NRN1L, PLAUR, PSCA, RAET1G, RAET1L, RECK, RTN4RL1, THY1"
"53","Nervous system development",104,570,0.0244,"ABLIM2, ANK2, ARHGEF28, CACNA1D, CACNA1H, CACNA1I, CACNB1, CACNB4, CNTNAP1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, CXCL12, CXCR4, CYP51A1, DCC, DPYSL3, DSCAM, EFNA3, EFNB3, EGFR, EPHA2, EPHA3, EPHA5, EPHB2, EVL, FYN, GAP43, GDNF, GFRA1, GRIN1, HOXA2, ISL1, ITGA1, ITGA5, ITGB1, ITGB3, KALRN, KCNQ3, L1CAM, LAMA1, LAMA2, LAMB1, LAMC1, LHX9, LYN, MBP, MET, MMP2, MMP9, MSN, MYL9, MYO10, NFASC, NRP1, NRP2, NTN4, PIK3CD, PIK3R3, PLXNA4, PLXND1, PRKCA, PRKCQ, PRNP, PSMB8, RELN, RET, RND1, ROBO3, RPS6KA6, SCD5, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SEMA3A, SEMA7A, SH3KBP1, SLIT2, SRC, TEAD1, TRPC1, TRPC3, TRPC4, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, UNC5A, UTRN, VAV3"
"54","Signaling by GPCR",175,1128,0.0308,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADGRE1, ADGRE5, ADM, ADORA2B, ADRA1B, ADRA2C, ADRB2, AGTR1, AKT3, ANXA1, APOA1, APOE, ARHGEF25, ARHGEF35, ARHGEF38, ARHGEF4, ARRB1, AVPR1A, AVPR2, AWAT2, C3, C5AR2, CALCRL, CAMK2A, CAMK4, CASR, CCL17, CCL20, CCR7, CCRL2, CGA, CMKLR1, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, CYSLTR1, DGKA, DGKB, DGKG, DRD1, EDN1, EDNRB, EGFR, F2R, F2RL1, F2RL3, FFAR2, FPR1, FZD2, FZD6, FZD7, GABBR1, GAL, GAST, GLP2R, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR17, GPR176, GPR20, GPSM3, GRM3, GRM4, GRM8, GRPR, GUCY2D, HBEGF, HCAR2, HCAR3, HRH1, HRH3, HSPG2, HTR1D, HTR2C, HTR4, KALRN, KISS1, LPAR1, LPAR3, LPAR5, LRP1, LRP12, LRP2, MC4R, MCF2, MTNR1A, NMU, NPFFR1, NPY1R, NPY4R, NPY5R, NTS, OR10A3, OR1F1, OR1Q1, OR2AG2, OR56A3, OR5AU1, OR7D2, P2RY1, P2RY10, P2RY2, PDE1A, PDE1C, PDE3A, PDE4A, PDE6B, PIK3R3, PIK3R5, PLA2G4A, PLB1, PLEKHG2, PLPPR1, PLPPR3, PLPPR4, PREX1, PRKCA, PRKCH, PRKCQ, PTGER3, PTGFR, PTH1R, QRFPR, RAMP1, RAMP2, RAMP3, RBP1, RBP4, REEP2, RGS16, RGS20, RGS4, RGS9, RTP3, S1PR1, SDC4, SDR9C7, SMO, SRC, STRA6, TAS2R46, TBXA2R, TIAM2, TRH, TRPC3, UTS2, UTS2B, VAV1, VAV3, VIPR1, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT6, WNT7A, XCL1, XK"
"55","Gap junction trafficking and regulation",15,47,0.0321,"DAB2, GJA1, GJA3, GJB2, GJB3, GJB6, GJC1, GJC2, SRC, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"56","Thyroxine biosynthesis",6,10,0.0327,"CGA, DIO1, DUOX1, DUOX2, IYD, TPO"
"57","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors",13,38,0.0332,"APOE, CGA, CGB5, CGB8, CITED1, CITED4, EGFR, ESR1, KCTD15, PITX2, TFAP2B, TFAP2C, TGFA"
"58","Stimuli-sensing channels",28,108,0.0332,"ANO1, ANO5, ASIC3, CLCA2, CLCN4, CLCNKB, FKBP1B, MCOLN2, MCOLN3, NALCN, RIPK3, SCNN1B, SGK1, SLC9B2, TRPC1, TRPC3, TRPC4, TRPM3, TRPM6, TRPV3, TRPV4, TRPV5, TRPV6, TSC22D3, TTYH2, UNC80, WNK3, WNK4"
"59","G alpha (z) signalling events",15,47,0.0382,"ADCY1, ADCY2, ADCY5, ADCY7, ADRA2C, GNG10, GNG11, GNG2, GNGT2, PRKCA, PRKCH, PRKCQ, RGS16, RGS20, RGS4"
"60","Transport of connexons to the plasma membrane",8,18,0.0389,"GJA1, GJB2, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"61","Signaling by PDGF",18,58,0.0389,"COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, PDGFC, PDGFRB, PLAT, SPP1, SRC, THBS1"
"62","PI5P, PP2A and IER3 Regulate PI3K AKT Signaling",26,102,0.0389,"EGFR, ESR1, FGF1, FGF2, FGF20, FGF5, FGFR2, FYN, HBEGF, IL1RAP, IL33, KL, LCK, MET, NRG1, NRG3, PDGFRB, PIK3AP1, PIK3CD, PIK3R3, PIP5K1B, RAC2, SRC, TGFA, TRAT1, VAV1"
"63","G alpha (i) signalling events",72,388,0.0392,"ADCY1, ADCY2, ADCY5, ADCY7, ADRA2C, ANXA1, APOA1, APOE, AWAT2, C3, CAMK2A, CAMK4, CASR, CCL20, CCR7, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, FPR1, GABBR1, GAL, GNG10, GNG11, GNG2, GNGT2, GPR17, GPSM3, GRM3, GRM4, GRM8, GUCY2D, HCAR2, HCAR3, HSPG2, HTR1D, LPAR1, LPAR3, LPAR5, LRP1, LRP12, LRP2, MTNR1A, NMU, NPY1R, NPY4R, NPY5R, PDE1A, PDE1C, PDE4A, PDE6B, PLA2G4A, PLB1, PRKCA, PRKCQ, PTGER3, RBP1, RBP4, RGS16, RGS20, RGS4, RGS9, SDC4, SDR9C7, SRC, STRA6, TAS2R46"
"64","Metabolism of amine-derived hormones",8,18,0.0398,"ASMT, CGA, DDC, DIO1, DUOX1, DUOX2, IYD, TPO"
"65","Axon guidance",98,545,0.0402,"ABLIM2, ANK2, ARHGEF28, CACNA1D, CACNA1H, CACNA1I, CACNB1, CACNB4, CNTNAP1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, CXCL12, CXCR4, DCC, DPYSL3, DSCAM, EFNA3, EFNB3, EGFR, EPHA2, EPHA3, EPHA5, EPHB2, EVL, FYN, GAP43, GDNF, GFRA1, GRIN1, HOXA2, ISL1, ITGA1, ITGA5, ITGB1, ITGB3, KALRN, KCNQ3, L1CAM, LAMA1, LAMB1, LAMC1, LHX9, LYN, MET, MMP2, MMP9, MSN, MYL9, MYO10, NFASC, NRP1, NRP2, NTN4, PIK3CD, PIK3R3, PLXNA4, PLXND1, PRKCA, PRKCQ, PRNP, PSMB8, RELN, RET, RND1, ROBO3, RPS6KA6, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SEMA3A, SEMA7A, SH3KBP1, SLIT2, SRC, TRPC1, TRPC3, TRPC4, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, UNC5A, VAV3"
"66","Diseases of glycosylation",34,142,0.0402,"ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, BGN, CHST3, CSPG4, DCN, EXT1, HSPG2, KERA, LARGE1, MUC13, MUC16, MUC19, MUC5B, MUCL1, PRELP, SDC4, SLC26A2, THBS1, THSD7A, VCAN"
"67","GABA B receptor activation",14,43,0.0402,"ADCY1, ADCY2, ADCY5, ADCY7, GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"68","Activation of GABAB receptors",14,43,0.0402,"ADCY1, ADCY2, ADCY5, ADCY7, GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"69","Signaling by MET",22,79,0.0421,"COL11A1, COL1A2, COL27A1, COL3A1, COL5A1, COL5A2, FN1, ITGA3, ITGB1, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, MET, SH3KBP1, SRC, TNS3"
"70","Inwardly rectifying K+ channels",12,35,0.0435,"ABCC9, GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ11, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"71","Gap junction trafficking",14,45,0.0444,"DAB2, GJA1, GJA3, GJB2, GJB3, GJB6, GJC1, GJC2, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"72","Negative regulation of the PI3K AKT network",27,109,0.0444,"AKT3, EGFR, ESR1, FGF1, FGF2, FGF20, FGF5, FGFR2, FYN, HBEGF, IL1RAP, IL33, KL, LCK, MET, NRG1, NRG3, PDGFRB, PIK3AP1, PIK3CD, PIK3R3, PIP5K1B, RAC2, SRC, TGFA, TRAT1, VAV1"
"73","Potassium Channels",26,103,0.0444,"ABCC9, GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNA7, KCNB2, KCNC4, KCND3, KCNG1, KCNG4, KCNH3, KCNH5, KCNJ11, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4, KCNN2, KCNN4, KCNQ3, KCNQ5, KCNS1, KCNS3"
"74","Ion channel transport",41,185,0.0444,"ANO1, ANO5, ASIC3, ATP10D, ATP13A4, ATP13A5, ATP2A3, ATP2C2, ATP6V0D2, ATP6V0E2, ATP8B3, CAMK2A, CLCA2, CLCN4, CLCNKB, FKBP1B, FXYD1, FXYD3, FXYD6, FXYD7, MCOLN2, MCOLN3, NALCN, RIPK3, SCNN1B, SGK1, SLC9B2, TRPC1, TRPC3, TRPC4, TRPM3, TRPM6, TRPV3, TRPV4, TRPV5, TRPV6, TSC22D3, TTYH2, UNC80, WNK3, WNK4"
"75","Smooth Muscle Contraction",13,40,0.0444,"ACTA2, ANXA1, ANXA2, CALD1, CAV3, DYSF, GUCY1A2, ITGA1, LMOD1, MYL9, MYLK, SORBS3, TPM2"
"76","Lysosphingolipid and LPA receptors",7,14,0.0444,"LPAR1, LPAR3, LPAR5, PLPPR1, PLPPR3, PLPPR4, S1PR1"
"77","GABA receptor activation",17,59,0.0577,"ADCY1, ADCY2, ADCY5, ADCY7, GABBR1, GABRA1, GABRA3, GABRG2, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"78","Dermatan sulfate biosynthesis",6,11,0.0655,"BGN, CSPG4, DCN, DSE, DSEL, VCAN"
"79","Defective CHST3 causes SEDCJD",5,8,0.0706,"BGN, CHST3, CSPG4, DCN, VCAN"
"80","Formation of Fibrin Clot (Clotting Cascade)",12,38,0.0725,"CD177, F2R, F3, F7, FGG, KLKB1, PRCP, PROCR, PROS1, SERPINE2, SERPING1, TFPI"
"81","Chemokine receptors bind chemokines",14,52,0.0725,"CCL17, CCL20, CCR7, CCRL2, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, XCL1"
"82","Cytokine Signaling in Immune system",142,858,0.0757,"ANGPT1, ANXA1, ANXA2, APBB1IP, ARRB1, BCL2, BIRC3, BLNK, BST2, CAMK2A, CCL20, CD40, CD44, CISH, CLCF1, CNKSR2, CNN2, CNTFR, COL1A2, CRLF2, CSF1, CSF2, CSF2RA, CTF1, CXCL1, CXCL2, CXCL8, DUSP4, DUSP9, EBI3, EGFR, FGF1, FGF2, FGF20, FGF5, FGFR2, FGG, FLNA, FN1, FPR1, FSCN1, FYN, GATA3, GBP1, GBP5, GDNF, GFRA1, GHR, GRIN1, HBEGF, HLA-A, HLA-B, HLA-DQA1, ICAM1, IFIT1, IFIT2, IFIT3, IFIT5, IFITM2, IFNA1, IFNLR1, IL12B, IL12RB2, IL18, IL1A, IL1R2, IL1RAP, IL1RAPL1, IL1RL2, IL20, IL22RA1, IL22RA2, IL27, IL31RA, IL32, IL33, IL6, IL7R, IRAK2, IRAK3, IRF7, ITGB1, ITGB2, ITGB3, KL, KSR1, LBP, LCK, LIF, LTB, LYN, MAPK10, MET, MID1, MMP2, MMP9, MRAS, MSN, MX2, NRG1, NRG3, OSMR, PDGFRB, PIK3CD, PIK3R3, PRKCQ, PRKG2, PRL, PRLR, PSMB8, PTGS2, RAG1, RASAL2, RASGRP3, RET, RHOU, RNASEL, RORC, S100A12, S1PR1, SERPINB2, SOX2, SRC, TEK, TGFA, TGFB1, TIMP1, TNFRSF11B, TNFRSF14, TNFRSF1B, TNFRSF9, TNFSF12, TNFSF14, TNFSF15, TNFSF18, TRIM10, TRIM29, TRIM3, TRIM48, VAV1, VIM, ZEB1"
"83","Activation of G protein gated Potassium channels",10,29,0.0757,"GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"84","G protein gated Potassium channels",10,29,0.0757,"GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"85","Inhibition  of voltage gated Ca2+ channels via Gbeta gamma subunits",10,29,0.0757,"GABBR1, GNG10, GNG11, GNG2, GNGT2, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4"
"86","ADP signalling through P2Y purinoceptor 1",9,25,0.079,"GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, P2RY1, PLA2G4A, SRC"
"87","Synthesis of 15-eicosatetraenoic acid derivatives",4,6,0.0827,"ALOX15B, GPX1, GPX2, PTGS2"
"88","Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane",7,17,0.0921,"GJA1, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"89","HDL remodeling",5,10,0.0959,"ABCG1, APOA1, APOE, LIPG, PLTP"
"90","ADORA2B mediated anti-inflammatory cytokines production",28,132,0.0979,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADM, ADORA2B, ADRB2, AVPR2, CALCRL, CGA, DRD1, GLP2R, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR176, GPR20, HTR4, IL6, MC4R, PTH1R, RAMP1, RAMP2, RAMP3, VIPR1"
"91","Cell-cell junction organization",17,63,0.1101,"CDH11, CDH13, CDH2, CDH3, CDH6, CDH7, CLDN1, CLDN10, CLDN11, CLDN16, CLDN18, CLDN3, CLDN6, CLDN8, NECTIN3, NECTIN4, PVR"
"92","Chondroitin sulfate biosynthesis",8,20,0.1118,"BGN, CHST13, CHST3, CHST7, CHSY3, CSPG4, DCN, VCAN"
"93","Signaling by Receptor Tyrosine Kinases",91,504,0.1126,"ADAM12, ADCYAP1, AKT3, APOE, ATP6V0D2, ATP6V0E2, AXL, BDNF, CAV1, COL11A1, COL1A2, COL27A1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, CXCL12, DUSP4, EGFR, ESR1, F3, FGF1, FGF2, FGF20, FGF5, FGFBP1, FGFR2, FLRT2, FLT4, FN1, FOSL1, FYN, GABRA1, GABRG2, HBEGF, HSPB1, ID2, ITGA3, ITGB1, ITGB3, KL, LAMA1, LAMA2, LAMA3, LAMA4, LAMB1, LAMB3, LAMC1, LAMC2, LAMC3, LCK, LYN, MET, MMP9, MST1R, NCF2, NGF, NRG1, NRG3, NRP1, NRP2, NTF3, NTF4, PDGFC, PDGFRB, PGF, PGR, PIK3R3, PLAT, PRKCA, RRAD, SGK1, SH2D2A, SH3KBP1, SPARC, SPP1, SPRY2, SRC, TGFA, THBS1, TNS3, VAV1, VAV3"
"94","PI3K AKT Signaling in Cancer",24,101,0.1126,"AKT3, EGFR, ESR1, FGF1, FGF2, FGF20, FGF5, FGFR2, FYN, HBEGF, KL, LCK, MET, NRG1, NRG3, PDGFRB, PIK3AP1, PIK3CD, PIK3R3, RAC2, SRC, TGFA, TRAT1, VAV1"
"95","Fibronectin matrix formation",4,6,0.1157,"CEACAM6, FN1, ITGA5, ITGB1"
"96","Calcitonin-like ligand receptors",5,10,0.1157,"ADM, CALCRL, RAMP1, RAMP2, RAMP3"
"97","WNT ligand biogenesis and trafficking",9,26,0.1232,"WLS, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT5B, WNT6, WNT7A"
"98","Basigin interactions",9,25,0.1267,"CAV1, ITGA3, ITGA6, ITGB1, L1CAM, SLC16A1, SLC16A3, SLC7A10, SLC7A7"
"99","Regulation of TLR by endogenous ligand",7,19,0.1373,"FGG, LBP, S100A1, S100A8, TLR1, TLR2, TLR6"
"100","Thrombin signalling through proteinase activated receptors (PARs)",10,32,0.1417,"ARRB1, F2R, F2RL3, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, SRC"
"101","Activation of Matrix Metalloproteinases",10,32,0.1417,"COL18A1, CTSV, KLKB1, MMP14, MMP2, MMP24, MMP9, SPOCK3, TIMP1, TIMP2"
"102","Anti-inflammatory response favouring Leishmania parasite infection",33,167,0.1681,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADM, ADORA2B, ADRB2, AVPR2, CALCRL, CGA, CYSLTR1, DRD1, FYN, GGT1, GLP2R, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR176, GPR20, HTR4, IL6, LYN, MC4R, PTH1R, RAMP1, RAMP2, RAMP3, SRC, VIPR1"
"103","Leishmania parasite growth and survival",33,167,0.1681,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADM, ADORA2B, ADRB2, AVPR2, CALCRL, CGA, CYSLTR1, DRD1, FYN, GGT1, GLP2R, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR176, GPR20, HTR4, IL6, LYN, MC4R, PTH1R, RAMP1, RAMP2, RAMP3, SRC, VIPR1"
"104","Arachidonic acid metabolism",15,58,0.1681,"ALOX15B, CYP1A2, CYP2U1, CYP4B1, CYP4F22, CYP4F8, FAAH, FAAH2, GGT1, GPX1, GPX2, PLA2G4A, PON3, PTGIS, PTGS2"
"105","Glycoprotein hormones",5,12,0.1681,"CGA, CGB5, CGB8, INHBA, INHBB"
"106","Transmission across Chemical Synapses",52,267,0.1681,"ABAT, ADCY1, ADCY2, ADCY5, ADCY7, BCHE, CACNA2D1, CACNB1, CACNB4, CACNG4, CAMK2A, CAMK4, CHAT, CPLX1, GABBR1, GABRA1, GABRA3, GABRG2, GAD1, GLRA3, GNG10, GNG11, GNG2, GNGT2, GRIK3, GRIK4, GRIN1, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4, KIF17, LIN7A, MAPT, NAAA, NCALD, NRG1, PRKCA, RAB3A, RIMS1, RPS6KA6, SLC1A1, SLC1A3, SLC6A11, SRC, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"107","Signal amplification",10,33,0.1681,"GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, P2RY1, PLA2G4A, SRC, TBXA2R"
"108","Creatine metabolism",5,11,0.1938,"CKB, CKM, CKMT1A, CKMT1B, SLC6A11"
"109","Transport of small molecules",121,724,0.2018,"ABCA12, ABCC11, ABCC4, ABCC9, ABCG1, ABCG2, ABCG4, ADCY1, ADCY2, ADCY5, ADCY7, ADD2, ADD3, AMN, ANO1, ANO5, APOA1, APOBR, APOC1, APOC4, APOE, AQP1, AQP5, AQP9, ASIC3, ATP10D, ATP13A4, ATP13A5, ATP2A3, ATP2C2, ATP6V0D2, ATP6V0E2, ATP8B3, AVPR2, AZGP1, CAMK2A, CFTR, CLCA2, CLCN4, CLCNKB, CUBN, CYGB, DMTN, FKBP1B, FXYD1, FXYD3, FXYD6, FXYD7, GNG10, GNG11, GNG2, GNGT2, HBA1, KCNJ11, LIPG, MB, MCOLN2, MCOLN3, MICU3, NALCN, NIPAL4, PCSK9, PIP, PLTP, PSMB8, RHBG, RIPK3, SCNN1B, SGK1, SLC11A1, SLC12A1, SLC12A5, SLC15A1, SLC16A1, SLC16A3, SLC16A7, SLC1A1, SLC1A3, SLC1A4, SLC22A15, SLC22A17, SLC24A3, SLC26A2, SLC27A6, SLC2A10, SLC2A12, SLC2A14, SLC2A3, SLC38A5, SLC44A4, SLC47A1, SLC4A10, SLC4A4, SLC5A8, SLC6A11, SLC6A15, SLC7A10, SLC7A7, SLC8A1, SLC9A6, SLC9A9, SLC9B2, SLCO1A2, SLCO1B1, SLCO1B3, SLCO2A1, STEAP2, TRPC1, TRPC3, TRPC4, TRPM3, TRPM6, TRPV3, TRPV4, TRPV5, TRPV6, TSC22D3, TTYH2, UNC80, WNK3, WNK4"
"110","Response to elevated platelet cytosolic Ca2+",28,133,0.207,"ABCC4, APOA1, CD109, CLEC3B, FGG, FLNA, FN1, GAS6, ISLR, ITGB3, PRKCA, PROS1, RAB27B, SELENOP, SELP, SERPINA3, SERPINE1, SERPINF2, SERPING1, SPARC, SRGN, TGFB1, TGFB2, TGFB3, THBS1, TIMP1, TIMP3, TUBA4A"
"111","Phase 2 - plateau phase",6,15,0.2184,"CACNB1, CACNG4, CACNG6, CACNG7, KCNE3, KCNE5"
"112","Platelet degranulation ",27,128,0.2184,"ABCC4, APOA1, CD109, CLEC3B, FGG, FLNA, FN1, GAS6, ISLR, ITGB3, PROS1, RAB27B, SELENOP, SELP, SERPINA3, SERPINE1, SERPINF2, SERPING1, SPARC, SRGN, TGFB1, TGFB2, TGFB3, THBS1, TIMP1, TIMP3, TUBA4A"
"113","Interaction between L1 and Ankyrins",10,31,0.2302,"ANK2, KCNQ3, L1CAM, NFASC, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A"
"114","Invadopodia formation",3,4,0.2392,"ADAM12, ADAM19, SH3PXD2A"
"115","Scavenging of heme from plasma",5,13,0.256,"APOA1, APOL1, HBA1, HPX, LRP1"
"116","GPVI-mediated activation cascade",10,34,0.2584,"COL1A2, FYN, LCK, LYN, PDPN, PIK3R3, PIK3R5, RAC2, VAV1, VAV3"
"117","Signaling by Interleukins",75,443,0.2643,"ANXA1, ANXA2, BCL2, BLNK, CCL20, CISH, CLCF1, CNN2, CNTFR, COL1A2, CRLF2, CSF1, CSF2, CSF2RA, CTF1, CXCL1, CXCL2, CXCL8, DUSP4, EBI3, FGF2, FN1, FPR1, FSCN1, FYN, GATA3, ICAM1, IFNLR1, IL12B, IL12RB2, IL18, IL1A, IL1R2, IL1RAP, IL1RAPL1, IL1RL2, IL20, IL22RA1, IL22RA2, IL27, IL31RA, IL32, IL33, IL6, IL7R, IRAK2, IRAK3, ITGB1, ITGB2, LBP, LCK, LIF, LYN, MAPK10, MMP2, MMP9, MSN, OSMR, PIK3CD, PIK3R3, PSMB8, PTGS2, RAG1, RHOU, RORC, S100A12, S1PR1, SERPINB2, SOX2, TGFB1, TIMP1, TNFRSF1B, VAV1, VIM, ZEB1"
"118","Formation of the cornified envelope",25,129,0.2644,"CASP14, DSG1, DSG3, DSG4, FLG, KLK13, KLK14, KLK5, KLK8, KRT14, KRT17, KRT2, KRT32, KRT33B, KRT34, KRT4, KRT79, KRT80, KRT81, KRT83, KRT85, LIPM, PKP2, SPINK6, SPRR2D"
"119","Termination of O-glycan biosynthesis",8,24,0.2647,"MUC13, MUC16, MUC19, MUC5B, MUCL1, ST6GALNAC2, ST6GALNAC3, ST6GALNAC4"
"120","PECAM1 interactions",5,11,0.2744,"FYN, ITGB3, LCK, LYN, SRC"
"121","Binding and Uptake of Ligands by Scavenger Receptors",11,42,0.2997,"APOA1, APOE, APOL1, COL1A2, COL3A1, COL4A1, COL4A2, HBA1, HPX, LRP1, SPARC"
"122","Voltage gated Potassium channels",12,43,0.3056,"KCNA7, KCNB2, KCNC4, KCND3, KCNG1, KCNG4, KCNH3, KCNH5, KCNQ3, KCNQ5, KCNS1, KCNS3"
"123","Acyl chain remodelling of PI",6,17,0.3078,"PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1"
"124","NFG and proNGF binds to p75NTR",2,2,0.3121,"NGF, NGFR"
"125","RUNX2 regulates genes involved in cell migration",4,8,0.3139,"AKT3, ITGA5, ITGBL1, RUNX2"
"126","FGFR2c ligand binding and activation",5,13,0.3139,"FGF1, FGF2, FGF20, FGF5, FGFR2"
"127","Defective CHST14 causes EDS, musculocontractural type",4,8,0.3218,"BGN, CSPG4, DCN, VCAN"
"128","Peptide hormone biosynthesis",5,14,0.3218,"CGA, CGB5, CGB8, INHBA, INHBB"
"129","Defective CHSY1 causes TPBS",4,8,0.3339,"BGN, CSPG4, DCN, VCAN"
"130","HDL clearance",3,5,0.342,"AMN, APOA1, CUBN"
"131","Antimicrobial peptides",16,89,0.3448,"ART1, BPIFA2, BPIFB1, BPIFB2, BPIFB6, CAMP, DEFB132, PGLYRP2, PLA2G2A, PRSS3, S100A7, S100A7A, S100A8, SLC11A1, TLR1, TLR2"
"132","Developmental Biology",162,1071,0.3473,"ABLIM2, ADIPOQ, AJUBA, AKT3, ANK2, ARHGEF28, CACNA1D, CACNA1H, CACNA1I, CACNB1, CACNB4, CACNG4, CASP14, CDH2, CEBPA, CNTNAP1, COL3A1, COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, COL5A1, COL5A2, COL6A1, COL6A2, COL9A1, COL9A3, CXCL12, CXCR4, CYP51A1, DCC, DPYSL3, DSCAM, DSG1, DSG3, DSG4, EFNA3, EFNB3, EGFR, EPHA2, EPHA3, EPHA5, EPHB2, EVL, FABP4, FGF2, FLG, FOXA3, FYN, GAP43, GDNF, GFRA1, GRIN1, H2AJ, HNF4A, HOXA1, HOXA2, HOXA3, HOXB4, ISL1, ITGA1, ITGA5, ITGB1, ITGB3, KALRN, KCNQ3, KLK13, KLK14, KLK5, KLK8, KRT14, KRT17, KRT2, KRT32, KRT33B, KRT34, KRT4, KRT79, KRT80, KRT81, KRT83, KRT85, KRTAP1-5, KRTAP2-3, KRTAP2-4, KRTAP3-1, KRTAP4-1, KRTAP4-8, L1CAM, LAMA1, LAMA2, LAMB1, LAMC1, LGI4, LHX9, LIPM, LYN, MAFB, MAML2, MBP, MET, MMP2, MMP9, MSN, MYB, MYL9, MYO10, NFASC, NKX2-2, NR2F2, NR5A2, NRP1, NRP2, NTN4, PIK3CD, PIK3R3, PKP2, PLXNA4, PLXND1, PRKCA, PRKCQ, PRNP, PSMB8, RELN, RET, RND1, ROBO3, RPS6KA6, SCD5, SCN1B, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A, SEMA3A, SEMA7A, SH3KBP1, SLIT2, SOX2, SPINK6, SPRR2D, SRC, TAL1, TCF4, TEAD1, TGFB1, TRPC1, TRPC3, TRPC4, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, UNC5A, UTRN, VAV3, ZIC3, ZNF467"
"133","Acyl chain remodelling of PS",7,22,0.3473,"OSBPL5, PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1"
"134","Metal sequestration by antimicrobial proteins",3,6,0.3482,"S100A7, S100A7A, S100A8"
"135","IL-6-type cytokine receptor ligand interactions",6,17,0.3561,"CLCF1, CNTFR, CTF1, IL31RA, LIF, OSMR"
"136","TGFBR2 MSI Frameshift Mutants in Cancer",2,2,0.3606,"TGFB1, TGFBR2"
"137","Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",2,2,0.3668,"ABCC9, KCNJ11"
"138","Extrinsic Pathway of Fibrin Clot Formation",3,5,0.3668,"F3, F7, TFPI"
"139","GPCR downstream signalling",152,1057,0.3672,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADM, ADORA2B, ADRA1B, ADRA2C, ADRB2, AGTR1, AKT3, ANXA1, APOA1, APOE, ARHGEF25, ARHGEF35, ARHGEF38, ARHGEF4, ARRB1, AVPR1A, AVPR2, AWAT2, C3, CALCRL, CAMK2A, CAMK4, CASR, CCL20, CCR7, CGA, CX3CR1, CXCL1, CXCL11, CXCL12, CXCL2, CXCL3, CXCL5, CXCL8, CXCR4, CYSLTR1, DGKA, DGKB, DGKG, DRD1, EDN1, EDNRB, EGFR, F2R, F2RL1, F2RL3, FFAR2, FPR1, GABBR1, GAL, GAST, GLP2R, GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR17, GPR176, GPR20, GPSM3, GRM3, GRM4, GRM8, GRPR, GUCY2D, HBEGF, HCAR2, HCAR3, HRH1, HSPG2, HTR1D, HTR2C, HTR4, KALRN, KISS1, LPAR1, LPAR3, LPAR5, LRP1, LRP12, LRP2, MC4R, MCF2, MTNR1A, NMU, NPFFR1, NPY1R, NPY4R, NPY5R, NTS, OR10A3, OR1F1, OR1Q1, OR2AG2, OR56A3, OR5AU1, OR7D2, P2RY1, P2RY10, P2RY2, PDE1A, PDE1C, PDE3A, PDE4A, PDE6B, PIK3R3, PIK3R5, PLA2G4A, PLB1, PLEKHG2, PREX1, PRKCA, PRKCH, PRKCQ, PTGER3, PTGFR, PTH1R, QRFPR, RAMP1, RAMP2, RAMP3, RBP1, RBP4, REEP2, RGS16, RGS20, RGS4, RGS9, RTP3, SDC4, SDR9C7, SRC, STRA6, TAS2R46, TBXA2R, TIAM2, TRH, TRPC3, UTS2, UTS2B, VAV1, VAV3, VIPR1, XCL1"
"140","O-linked glycosylation of mucins",15,62,0.3672,"A4GNT, B3GNT3, B3GNT5, B3GNT7, CHST4, GALNT5, GALNTL6, MUC13, MUC16, MUC19, MUC5B, MUCL1, ST6GALNAC2, ST6GALNAC3, ST6GALNAC4"
"141","Nuclear signaling by ERBB4",9,32,0.3721,"APOE, CXCL12, ESR1, HBEGF, NRG1, NRG3, PGR, SPARC, SRC"
"142","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",9,31,0.3811,"BLNK, CD22, FYN, LYN, PIK3AP1, PIK3CD, SH3KBP1, TRPC1, VAV1"
"143","Glycosaminoglycan metabolism",26,124,0.3811,"B3GNT3, B3GNT7, BGN, CD44, CEMIP, CHST1, CHST13, CHST3, CHST7, CHSY3, CSPG4, DCN, DSE, DSEL, EXT1, HAS2, HPSE, HS3ST1, HS3ST3B1, HS6ST3, HSPG2, KERA, PRELP, SDC4, SLC26A2, VCAN"
"144","MET interacts with TNS proteins",3,5,0.3811,"ITGB1, MET, TNS3"
"145","Netrin-1 signaling",13,50,0.3811,"ABLIM2, DCC, DSCAM, FYN, MYO10, NTN4, PRKCQ, SLIT2, SRC, TRPC1, TRPC3, TRPC4, UNC5A"
"146","Cytochrome P450 - arranged by substrate type",15,64,0.3832,"CYP11A1, CYP1A2, CYP24A1, CYP26A1, CYP27A1, CYP2A6, CYP2A7, CYP2E1, CYP2S1, CYP2U1, CYP4B1, CYP4F22, CYP4F8, CYP51A1, PTGIS"
"147","Reelin signalling pathway",3,5,0.3893,"FYN, RELN, SH3KBP1"
"148","Acyl chain remodelling of PG",6,18,0.3912,"PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1"
"149","Diseases associated with glycosaminoglycan metabolism",11,41,0.3988,"BGN, CHST3, CSPG4, DCN, EXT1, HSPG2, KERA, PRELP, SDC4, SLC26A2, VCAN"
"150","Tight junction interactions",8,28,0.4,"CLDN1, CLDN10, CLDN11, CLDN16, CLDN18, CLDN3, CLDN6, CLDN8"
"151","Thromboxane signalling through TP receptor",7,24,0.4098,"GNA14, GNA15, GNG10, GNG11, GNG2, GNGT2, TBXA2R"
"152","Extra-nuclear estrogen signaling",17,77,0.4112,"AKT3, BCL2, CAV1, CAV2, EGFR, ESR1, GNG10, GNG11, GNG2, GNGT2, HBEGF, HSPB1, MMP2, MMP9, PIK3R3, SRC, TGFA"
"153","Tryptophan catabolism",5,14,0.413,"AADAT, ACMSD, IDO1, KMO, KYNU"
"154","FGFR2 ligand binding and activation",6,20,0.4352,"FGF1, FGF2, FGF20, FGF5, FGFBP1, FGFR2"
"155","FGFR2b ligand binding and activation",4,10,0.4364,"FGF1, FGF2, FGFBP1, FGFR2"
"156","Scavenging by Class A Receptors",6,19,0.4414,"APOA1, APOE, COL1A2, COL3A1, COL4A1, COL4A2"
"157","Sphingolipid de novo biosynthesis",11,43,0.4424,"ACER1, ACER2, ALDH3B1, DEGS2, FA2H, PPM1L, PRKD1, PRKD3, SGPP1, SPTLC3, SPTSSB"
"158","Neurotransmitter receptors and postsynaptic signal transmission",38,202,0.4605,"ADCY1, ADCY2, ADCY5, ADCY7, CACNG4, CAMK2A, CAMK4, GABBR1, GABRA1, GABRA3, GABRG2, GLRA3, GNG10, GNG11, GNG2, GNGT2, GRIK3, GRIK4, GRIN1, KCNJ15, KCNJ16, KCNJ2, KCNJ3, KCNJ4, KIF17, LIN7A, MAPT, NCALD, NRG1, PRKCA, RPS6KA6, SRC, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"159","VLDL clearance",3,6,0.4605,"APOBR, APOC1, APOC4"
"160","Regulation of Complement cascade",11,46,0.4655,"C1R, C3, C4BPB, C5AR2, C6, CFH, CFHR3, CR2, PROS1, SERPING1, VTN"
"161","Platelet Adhesion to exposed collagen",5,14,0.4669,"COL1A2, FYN, ITGA1, ITGB1, LYN"
"162","Signaling by BMP",8,27,0.4669,"ACVRL1, BMP10, BMP2, CHRDL1, FSTL1, NOG, SMAD9, SMURF2"
"163","NADE modulates death signalling",3,6,0.4669,"BEX3, NGF, NGFR"
"164","Synthesis of PA",10,39,0.515,"AGPAT4, ALPI, GPAT3, GPD1L, PLA2G2A, PLA2G2E, PLA2G4A, PLA2G5, PLA2R1, PLD1"
"165","Adherens junctions interactions",9,33,0.515,"CDH11, CDH13, CDH2, CDH3, CDH6, CDH7, NECTIN3, NECTIN4, PVR"
"166","Assembly and cell surface presentation of NMDA receptors",10,39,0.5357,"CAMK2A, GRIN1, KIF17, LIN7A, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"167","Diseases of metabolism",44,243,0.5358,"ADAMTS10, ADAMTS12, ADAMTS14, ADAMTS16, ADAMTS18, ADAMTS19, ADAMTS20, ADAMTS3, ADAMTS6, ADAMTS7, ADAMTS8, ADAMTS9, ADAMTSL1, ADAMTSL2, ADAMTSL4, AMN, BGN, CHST3, CSF2RA, CSPG4, CUBN, CYP11A1, CYP24A1, CYP27A1, CYP2U1, CYP4F22, DCN, EXT1, GGT1, GYS2, HSPG2, KERA, LARGE1, MUC13, MUC16, MUC19, MUC5B, MUCL1, PRELP, SDC4, SLC26A2, THBS1, THSD7A, VCAN"
"168","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",23,124,0.5363,"C3, CD200, CD22, CD40, CD8A, CD8B, COL17A1, COL1A2, COL3A1, CRTAM, HLA-A, HLA-B, ICAM1, ICAM2, ICAM5, ITGA4, ITGB1, ITGB2, PVR, RAET1E, SLAMF7, TREML2, ULBP3"
"169","Aquaporin-mediated transport",12,52,0.5363,"ADCY1, ADCY2, ADCY5, ADCY7, AQP1, AQP5, AQP9, AVPR2, GNG10, GNG11, GNG2, GNGT2"
"170","Proton-coupled monocarboxylate transport",3,6,0.5363,"SLC16A1, SLC16A3, SLC16A7"
"171","SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion",5,14,0.5363,"FYN, NRP1, PLXNA4, RND1, SEMA3A"
"172","Interleukin-6 family signaling",7,24,0.5363,"CLCF1, CNTFR, CTF1, IL31RA, IL6, LIF, OSMR"
"173","GABA synthesis, release, reuptake and degradation",6,19,0.5363,"ABAT, CPLX1, GAD1, RAB3A, RIMS1, SLC6A11"
"174","PTK6 promotes HIF1A stabilization",3,6,0.5363,"EGFR, HBEGF, LRRK2"
"175","RUNX1 regulates transcription of genes involved in WNT signaling",3,6,0.5363,"ESR1, FOXP3, RSPO3"
"176","RUNX3 Regulates Immune Response and Cell Migration",3,6,0.5363,"ITGA4, RORC, SPP1"
"177","Phenylalanine and tyrosine metabolism",4,11,0.5363,"ASRGL1, HGD, IL4I1, TAT"
"178","EPH-ephrin mediated repulsion of cells",12,51,0.5363,"EFNA3, EFNB3, EPHA2, EPHA3, EPHA5, EPHB2, FYN, LYN, MMP2, MMP9, SRC, VAV3"
"179","Nucleotide-like (purinergic) receptors",5,15,0.5363,"ADORA2B, GPR17, P2RY1, P2RY10, P2RY2"
"180","Post-chaperonin tubulin folding pathway",6,21,0.5363,"TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"181","Ceramide signalling",2,3,0.5363,"NGF, NGFR"
"182","Intracellular oxygen transport",2,3,0.5363,"CYGB, MB"
"183","Phospholipase C-mediated cascade- FGFR1",5,16,0.5363,"FGF1, FGF2, FGF20, FGF5, KL"
"184","Eicosanoid ligand-binding receptors",5,15,0.5363,"CYSLTR1, GPR17, PTGER3, PTGFR, TBXA2R"
"185","FGFR1 ligand binding and activation",5,16,0.5363,"FGF1, FGF2, FGF20, FGF5, KL"
"186","CYP2E1 reactions",4,11,0.5363,"CYP2A6, CYP2A7, CYP2E1, CYP2S1"
"187","EGR2 and SOX10-mediated initiation of Schwann cell myelination",8,28,0.5363,"CYP51A1, LAMA2, LAMB1, LAMC1, MBP, SCD5, TEAD1, UTRN"
"188","Signaling by activated point mutants of FGFR1",4,11,0.5363,"FGF1, FGF2, FGF20, FGF5"
"189","Defective AMN causes hereditary megaloblastic anemia 1",2,3,0.5363,"AMN, CUBN"
"190","Defective CUBN causes hereditary megaloblastic anemia 1",2,3,0.5363,"AMN, CUBN"
"191","Negative regulation of TCF-dependent signaling by WNT ligand antagonists",5,15,0.5363,"DKK1, SFRP1, SOST, WIF1, WNT4"
"192","Chondroitin sulfate dermatan sulfate metabolism",12,50,0.5363,"BGN, CHST13, CHST3, CHST7, CHSY3, CSPG4, DCN, DSE, DSEL, HSPG2, SDC4, VCAN"
"193","Retinoid metabolism and transport",10,43,0.5363,"APOA1, APOE, HSPG2, LRP1, LRP12, LRP2, PLB1, RBP1, RBP4, SDC4"
"194","Oligomerization of connexins into connexons",2,3,0.5363,"GJA1, GJB2"
"195","Transport of connexins along the secretory pathway",2,3,0.5363,"GJA1, GJB2"
"196","EPHA-mediated growth cone collapse",8,30,0.5363,"EFNA3, EPHA2, EPHA3, EPHA5, FYN, LYN, MYL9, SRC"
"197","Ca-dependent events",10,39,0.5363,"ADCY1, ADCY2, ADCY5, ADCY7, CAMK2A, CAMK4, PDE1A, PDE1C, PLA2G4A, PRKCA"
"198","Defective SERPING1 causes hereditary angioedema",2,3,0.5641,"KLKB1, SERPING1"
"199","p130Cas linkage to MAPK signaling for integrins",5,15,0.5652,"APBB1IP, FGG, FN1, ITGB3, SRC"
"200","Regulation of commissural axon pathfinding by SLIT and ROBO",4,10,0.5652,"DCC, ROBO3, SLIT2, SRC"
"201","Activated point mutants of FGFR2",5,17,0.5668,"FGF1, FGF2, FGF20, FGF5, FGFR2"
"202","Role of second messengers in netrin-1 signaling",4,10,0.568,"DCC, TRPC1, TRPC3, TRPC4"
"203","GRB2-SOS provides linkage to MAPK signaling for Integrins ",5,15,0.5736,"APBB1IP, FGG, FN1, ITGB3, SRC"
"204","Leishmania infection",42,248,0.5759,"ADCY1, ADCY2, ADCY5, ADCY7, ADCYAP1, ADM, ADORA2B, ADRB2, AVPR2, C3, CALCRL, CGA, CYSLTR1, DRD1, FYN, FZD7, GGT1, GLP2R, GNG10, GNG11, GNG2, GNGT2, GPR15, GPR176, GPR20, HTR4, IL18, IL1A, IL6, LYN, MC4R, MYO10, NOXA1, NT5E, PTH1R, RAMP1, RAMP2, RAMP3, SRC, VAV1, VAV3, VIPR1"
"205","Adenylate cyclase activating pathway",4,10,0.5768,"ADCY1, ADCY2, ADCY5, ADCY7"
"206","Hydroxycarboxylic acid-binding receptors",2,3,0.5813,"HCAR2, HCAR3"
"207","Nicotinate metabolism",8,31,0.5975,"NMNAT2, NNMT, NT5E, PARP4, PTGIS, PTGS2, QPRT, SLC5A8"
"208","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway",5,17,0.6031,"BIRC3, CD40, LTB, TNFSF12, TNFSF14"
"209","Common Pathway of Fibrin Clot Formation",6,22,0.6031,"CD177, F2R, FGG, PROCR, PROS1, SERPINE2"
"210","GLI proteins bind promoters of Hh responsive genes to promote transcription",2,3,0.6055,"GLI2, GLI3"
"211","Defective B3GAT3 causes JDSSDHD",6,20,0.6089,"BGN, CSPG4, DCN, HSPG2, SDC4, VCAN"
"212","Interleukin-33 signaling",2,3,0.6089,"IL1RAP, IL33"
"213","Regulation of gap junction activity",2,3,0.6089,"GJA1, SRC"
"214","Defective B4GALT7 causes EDS, progeroid type",6,20,0.6091,"BGN, CSPG4, DCN, HSPG2, SDC4, VCAN"
"215","Vasopressin regulates renal water homeostasis via Aquaporins",10,43,0.6123,"ADCY1, ADCY2, ADCY5, ADCY7, AQP1, AVPR2, GNG10, GNG11, GNG2, GNGT2"
"216","Kinesins",13,58,0.6123,"KIF1A, KIF26A, KIF26B, KIF3C, KIF5A, KIFC2, KLC3, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"217","Defective B3GALT6 causes EDSP2 and SEMDJL1",6,20,0.6123,"BGN, CSPG4, DCN, HSPG2, SDC4, VCAN"
"218","Synthesis of 5-eicosatetraenoic acids",3,8,0.6164,"GPX1, GPX2, PON3"
"219","Signaling by activated point mutants of FGFR3",4,12,0.6184,"FGF1, FGF2, FGF20, FGF5"
"220","FGFR3 mutant receptor activation",4,12,0.6184,"FGF1, FGF2, FGF20, FGF5"
"221","Acyl chain remodelling of PC",7,27,0.6184,"PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1, PLB1"
"222","Loss of Function of TGFBR2 in Cancer",2,3,0.6231,"TGFB1, TGFBR2"
"223","TGFBR2 Kinase Domain Mutants in Cancer",2,3,0.6231,"TGFB1, TGFBR2"
"224","The NLRP1 inflammasome",2,3,0.6276,"BCL2, NLRP1"
"225","Nectin Necl  trans heterodimerization",3,7,0.6282,"NECTIN3, NECTIN4, PVR"
"226","Signal transduction by L1",6,21,0.6282,"EGFR, ITGA5, ITGB1, ITGB3, L1CAM, NRP1"
"227","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs IMPs VICKZs) bind RNA",2,3,0.6282,"IGF2BP2, IGF2BP3"
"228","Glycerophospholipid catabolism",3,7,0.6282,"ENPP6, GDPD3, PNPLA7"
"229","FGFR1c ligand binding and activation",4,12,0.6363,"FGF1, FGF2, FGF20, FGF5"
"230","TNFs bind their physiological receptors",7,29,0.6412,"TNFRSF11B, TNFRSF14, TNFRSF1B, TNFRSF9, TNFSF14, TNFSF15, TNFSF18"
"231","Receptor-type tyrosine-protein phosphatases",6,20,0.6412,"IL1RAP, IL1RAPL1, PPFIBP2, SLITRK4, SLITRK5, SLITRK6"
"232","Phospholipase C-mediated cascade; FGFR2",5,18,0.6412,"FGF1, FGF2, FGF20, FGF5, FGFR2"
"233","Dectin-2 family",7,27,0.6412,"FYN, LYN, MUC13, MUC16, MUC19, MUC5B, MUCL1"
"234","Phase 1 - inactivation of fast Na+ channels",3,7,0.643,"KCND3, KCNIP1, KCNIP3"
"235","Plasma lipoprotein clearance",8,33,0.6448,"AMN, APOA1, APOBR, APOC1, APOC4, APOE, CUBN, PCSK9"
"236","Activation of the TFAP2 (AP-2) family of transcription factors",4,12,0.671,"CITED1, CITED4, TFAP2B, TFAP2C"
"237","P2Y receptors",4,12,0.6732,"GPR17, P2RY1, P2RY10, P2RY2"
"238","CRMPs in Sema3A signaling",5,16,0.6738,"DPYSL3, FYN, NRP1, PLXNA4, SEMA3A"
"239","Regulation of KIT signaling",5,16,0.6768,"FYN, LCK, LYN, PRKCA, SRC"
"240","Eicosanoids",4,12,0.6883,"CYP4B1, CYP4F22, CYP4F8, PTGIS"
"241","Regulation of signaling by CBL",6,22,0.6883,"BLNK, FYN, LYN, PIK3CD, PIK3R3, VAV1"
"242","Adrenaline,noradrenaline inhibits insulin secretion",7,28,0.6883,"ADCY5, ADRA2C, CACNA1D, GNG10, GNG11, GNG2, GNGT2"
"243","Acyl chain remodelling of PE",7,29,0.6883,"PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1, PLAAT2"
"244","Activated NTRK2 signals through FYN",3,7,0.6883,"BDNF, FYN, SRC"
"245","Miscellaneous substrates",4,12,0.6883,"CYP2S1, CYP2U1, CYP4B1, CYP4F22"
"246","Activation of AMPK downstream of NMDARs",7,28,0.6895,"MAPT, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"247","Metabolism of fat-soluble vitamins",10,47,0.6967,"APOA1, APOE, HSPG2, LRP1, LRP12, LRP2, PLB1, RBP1, RBP4, SDC4"
"248","Transport of organic anions",4,12,0.7026,"SLCO1A2, SLCO1B1, SLCO1B3, SLCO2A1"
"249","Rho GTPase cycle",26,135,0.7026,"ARAP3, ARHGAP18, ARHGAP22, ARHGAP29, ARHGAP31, ARHGAP36, ARHGAP42, ARHGEF35, ARHGEF38, ARHGEF4, DEPDC7, DLC1, KALRN, MCF2, PLEKHG2, PREX1, RAC2, RHOH, RHOJ, RHOU, RHOV, STARD8, SYDE1, TIAM2, VAV1, VAV3"
"250","Calmodulin induced events",9,37,0.7026,"ADCY1, ADCY2, ADCY5, ADCY7, CAMK2A, CAMK4, PDE1A, PDE1C, PRKCA"
"251","CaM pathway",9,37,0.7026,"ADCY1, ADCY2, ADCY5, ADCY7, CAMK2A, CAMK4, PDE1A, PDE1C, PRKCA"
"252","FGFR3 ligand binding and activation",4,13,0.7026,"FGF1, FGF2, FGF20, FGF5"
"253","FGFR3c ligand binding and activation",4,13,0.7026,"FGF1, FGF2, FGF20, FGF5"
"254","Signaling by Overexpressed Wild-Type EGFR in Cancer",3,8,0.7026,"EGFR, HBEGF, TGFA"
"255","Inhibition of Signaling by Overexpressed EGFR",3,8,0.7026,"EGFR, HBEGF, TGFA"
"256","Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)",5,17,0.7139,"MUC13, MUC16, MUC19, MUC5B, MUCL1"
"257","Interleukin-38 signaling",2,4,0.714,"IL1RAPL1, IL1RL2"
"258","Defective GALNT12 causes colorectal cancer 1 (CRCS1)",5,17,0.714,"MUC13, MUC16, MUC19, MUC5B, MUCL1"
"259","Phospholipase C-mediated cascade; FGFR3",4,13,0.714,"FGF1, FGF2, FGF20, FGF5"
"260","Detoxification of Reactive Oxygen Species",8,37,0.7169,"GPX1, GPX2, GPX3, GPX7, GPX8, GSTP1, NCF2, SOD3"
"261","Striated Muscle Contraction",8,36,0.7169,"MYL2, MYL3, MYL4, TMOD2, TNNC1, TNNT1, TPM2, VIM"
"262","The activation of arylsulfatases",4,13,0.7322,"ARSH, ARSI, ARSL, STS"
"263","Aggrephagy",9,41,0.7331,"CFTR, DYNC1I1, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, VIM"
"264","Axonal growth stimulation",2,4,0.7331,"NGF, NGFR"
"265","Presynaptic depolarization and calcium channel opening",4,12,0.7331,"CACNA2D1, CACNB1, CACNB4, CACNG4"
"266","Amine ligand-binding receptors",9,41,0.7331,"ADRA1B, ADRA2C, ADRB2, DRD1, HRH1, HRH3, HTR1D, HTR2C, HTR4"
"267","G beta-gamma signalling through PI3Kgamma",6,24,0.7357,"AKT3, GNG10, GNG11, GNG2, GNGT2, PIK3R5"
"268","Signaling by ERBB4",12,57,0.7404,"APOE, CXCL12, EGFR, ESR1, GABRA1, GABRG2, HBEGF, NRG1, NRG3, PGR, SPARC, SRC"
"269","Adrenoceptors",3,8,0.7499,"ADRA1B, ADRA2C, ADRB2"
"270","Keratinization",31,212,0.7514,"CASP14, DSG1, DSG3, DSG4, FLG, KLK13, KLK14, KLK5, KLK8, KRT14, KRT17, KRT2, KRT32, KRT33B, KRT34, KRT4, KRT79, KRT80, KRT81, KRT83, KRT85, KRTAP1-5, KRTAP2-3, KRTAP2-4, KRTAP3-1, KRTAP4-1, KRTAP4-8, LIPM, PKP2, SPINK6, SPRR2D"
"271","Interferon alpha beta signaling",13,70,0.756,"BST2, HLA-A, HLA-B, IFIT1, IFIT2, IFIT3, IFIT5, IFITM2, IFNA1, IRF7, MX2, PSMB8, RNASEL"
"272","Recycling pathway of L1",10,46,0.7755,"L1CAM, MSN, RPS6KA6, SRC, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"273","Utilization of Ketone Bodies",2,4,0.7967,"BDH1, OXCT2"
"274","Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)",5,18,0.7967,"MUC13, MUC16, MUC19, MUC5B, MUCL1"
"275","Intraflagellar transport",11,54,0.7973,"DYNC2H1, DYNLRB2, IFT57, IFT74, KIF17, KIF3C, TUBA4A, TUBB2B, TUBB3, TUBB4A, TUBB6"
"276","ERBB2 Activates PTK6 Signaling",4,13,0.7996,"EGFR, HBEGF, NRG1, NRG3"
"277","G alpha (12 13) signalling events",16,80,0.802,"ADRA1B, ARHGEF35, ARHGEF38, ARHGEF4, GNG10, GNG11, GNG2, GNGT2, KALRN, MCF2, PLEKHG2, PREX1, TBXA2R, TIAM2, VAV1, VAV3"
"278","TGFBR1 LBD Mutants in Cancer",2,4,0.802,"TGFB1, TGFBR2"
"279","Neurotransmitter release cycle",11,51,0.8144,"ABAT, CHAT, CPLX1, GAD1, LIN7A, NAAA, RAB3A, RIMS1, SLC1A1, SLC1A3, SLC6A11"
"280","TFAP2 (AP-2) family regulates transcription of other transcription factors",2,4,0.8144,"PITX2, TFAP2C"
"281","Visual phototransduction",18,99,0.8144,"APOA1, APOE, AWAT2, GUCY2D, HSPG2, LRP1, LRP12, LRP2, PDE6B, PLB1, PRKCA, PRKCQ, RBP1, RBP4, RGS9, SDC4, SDR9C7, STRA6"
"282","Cell-extracellular matrix interactions",5,18,0.8144,"FBLIM1, FLNA, FLNC, ITGB1, LIMS2"
"283","Activated NTRK2 signals through PLCG1",2,4,0.8144,"BDNF, NTF4"
"284","Gamma carboxylation, hypusine formation and arylsulfatase activation",9,42,0.8144,"ARSH, ARSI, ARSL, EIF5A2, F7, GAS6, PROS1, STS, TPST1"
"285","Histamine receptors",2,4,0.8144,"HRH1, HRH3"
"286","Formation of tubulin folding intermediates by CCT TriC",6,25,0.8144,"TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"287","Phase II - Conjugation of compounds",18,102,0.8246,"ACSM1, CYP1A2, ESD, GGT1, GGT6, GLYAT, GSTA3, GSTM3, GSTM5, GSTP1, NAT1, NNMT, SLC26A2, SULT1A1, SULT4A1, TPST1, UGT2B15, UGT2B17"
"288","Netrin mediated repulsion signals",3,8,0.8246,"DCC, SRC, UNC5A"
"289","Heme degradation",4,14,0.8246,"ABCG2, BLVRB, SLCO1B1, SLCO1B3"
"290","Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus",3,9,0.8246,"F7, GAS6, PROS1"
"291","Signaling by Activin",4,13,0.8284,"FST, FSTL3, INHBA, INHBB"
"292","ATP sensitive Potassium channels",2,4,0.8284,"ABCC9, KCNJ11"
"293","Retinoid metabolism disease events",1,1,0.8336,"RBP4"
"294","Classical Kir channels",2,4,0.8336,"KCNJ2, KCNJ4"
"295","Glucagon-type ligand receptors",7,33,0.8482,"ADCYAP1, GLP2R, GNG10, GNG11, GNG2, GNGT2, VIPR1"
"296","EGFR interacts with phospholipase C-gamma",3,9,0.854,"EGFR, HBEGF, TGFA"
"297","Complement cascade",11,57,0.854,"C1R, C3, C4BPB, C5AR2, C6, CFH, CFHR3, CR2, PROS1, SERPING1, VTN"
"298","Sperm Motility And Taxes",3,9,0.8634,"CATSPER1, CATSPERB, KCNU1"
"299","Neurophilin interactions with VEGF and VEGFR",2,4,0.8634,"NRP1, NRP2"
"300","Nicotinamide salvaging",5,19,0.896,"NNMT, PARP4, PTGIS, PTGS2, SLC5A8"
"301","Signaling by high-kinase activity BRAF mutants",8,36,0.896,"APBB1IP, ARRB1, CNKSR2, FGG, FN1, ITGB3, KSR1, SRC"
"302","RHO GTPases activate IQGAPs",7,31,0.897,"IQGAP2, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"303","Prostanoid ligand receptors",3,9,0.905,"PTGER3, PTGFR, TBXA2R"
"304","Carboxyterminal post-translational modifications of tubulin",8,37,0.905,"AGBL4, LRRC49, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6"
"305","Tyrosine catabolism",2,5,0.911,"HGD, TAT"
"306","Serotonin and melatonin biosynthesis",2,5,0.911,"ASMT, DDC"
"307","Glutathione conjugation",7,35,0.911,"ESD, GGT1, GGT6, GSTA3, GSTM3, GSTM5, GSTP1"
"308","Acetylcholine regulates insulin secretion",3,9,0.9146,"GNA14, GNA15, PRKCA"
"309","CS DS degradation",4,14,0.9146,"BGN, CSPG4, DCN, VCAN"
"310","VLDL assembly",2,5,0.9146,"APOC1, APOC4"
"311","EGFR Transactivation by Gastrin",3,9,0.9146,"EGFR, HBEGF, PRKCA"
"312","Other semaphorin interactions",5,19,0.9146,"ITGA1, ITGB1, PLXNA4, PLXND1, SEMA7A"
"313","Metabolism of lipids",110,729,0.9146,"ACER1, ACER2, ACOT11, ACOT4, ACOT6, ACOX2, ACSL4, AGMO, AGPAT4, AGPS, AKR1B1, ALDH3B1, ALOX15B, ALPI, ANKRD1, APOA1, ARSH, ARSI, ARSL, AWAT2, BCHE, BDH1, CAV1, CGA, CHAT, CPNE6, CUBN, CYP11A1, CYP1A2, CYP24A1, CYP27A1, CYP2E1, CYP2U1, CYP4B1, CYP4F22, CYP4F8, CYP51A1, DBI, DEGS2, ELOVL2, ELOVL4, ENPP6, ETNPPL, FA2H, FAAH, FAAH2, FABP3, FABP4, FABP5, FHL2, G0S2, GDPD3, GGT1, GLIPR1, GPAT3, GPD1L, GPX1, GPX2, GRHL1, HACD1, HMGCS2, HSD17B11, HSD3B1, INPP5J, LRP2, MOGAT2, MTMR8, NPAS2, OSBPL3, OSBPL5, OXCT2, PCYT1B, PIK3CD, PIK3R3, PIK3R5, PIP5K1B, PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1, PLAAT2, PLB1, PLD1, PLEKHA2, PNPLA5, PNPLA7, PON3, PPM1L, PRKD1, PRKD3, PTGIS, PTGS2, SCD5, SGPP1, SLC27A3, SLC44A4, SLCO1A2, SLCO1B1, SLCO1B3, SPTLC3, SPTSSB, STARD10, STARD4, STS, THRSP, TIAM2, TNFRSF21, UGT8"
"314","Presynaptic function of Kainate receptors",5,21,0.9505,"GNG10, GNG11, GNG2, GNGT2, GRIK3"
"315","SHC-mediated cascade-FGFR1",5,21,0.9635,"FGF1, FGF2, FGF20, FGF5, KL"
"316","Activation of kainate receptors upon glutamate binding",7,32,0.9639,"GNG10, GNG11, GNG2, GNGT2, GRIK3, GRIK4, NCALD"
"317","Fatty acids",4,15,0.9639,"CYP2A7, CYP4B1, CYP4F22, CYP4F8"
"318","Ion homeostasis",11,55,0.9639,"ABCC9, ATP2A3, CAMK2A, FKBP1B, FXYD1, FXYD3, FXYD6, FXYD7, KCNJ11, SLC8A1, TRPC1"
"319","CD22 mediated BCR regulation",2,5,0.9639,"CD22, LYN"
"320","MyD88 deficiency (TLR2 4)",3,10,0.9639,"TLR1, TLR2, TLR6"
"321","NRAGE signals death through JNK",12,58,0.9676,"ARHGEF35, ARHGEF38, ARHGEF4, KALRN, MCF2, NGF, NGFR, PLEKHG2, PREX1, TIAM2, VAV1, VAV3"
"322","RAB geranylgeranylation",12,64,0.9676,"RAB15, RAB19, RAB25, RAB26, RAB27B, RAB32, RAB34, RAB38, RAB3A, RAB3B, RAB42, RAB9B"
"323","Negative regulation of FGFR1 signaling",7,33,0.9676,"FGF1, FGF2, FGF20, FGF5, KL, SPRY2, SRC"
"324","DCC mediated attractive signaling",4,14,0.9699,"ABLIM2, DCC, FYN, SRC"
"325","Gamma-carboxylation of protein precursors",3,10,0.9699,"F7, GAS6, PROS1"
"326","Leukotriene receptors",2,5,0.9699,"CYSLTR1, GPR17"
"327","Immune System",295,2097,0.9699,"ACP3, ADGRE5, AIM2, AKT3, ALDH3B1, ANGPT1, ANXA1, ANXA2, APBB1IP, ARRB1, ART1, ASB15, ASB2, ATP6V0D2, ATP6V0E2, BCL2, BIRC3, BLNK, BPIFA2, BPIFB1, BPIFB2, BPIFB6, BST2, BTN1A1, BTN2A2, C1R, C3, C4BPB, C5AR2, C6, CALML5, CAMK2A, CAMP, CARD11, CCL20, CD177, CD200, CD22, CD274, CD40, CD44, CD74, CD8A, CD8B, CDA, CEACAM6, CFH, CFHR3, CGAS, CISH, CLCF1, CNKSR2, CNN2, CNTFR, COL17A1, COL1A2, COL3A1, COTL1, CR2, CRISP3, CRLF2, CRTAM, CSF1, CSF2, CSF2RA, CTF1, CTSC, CTSE, CTSF, CTSV, CXCL1, CXCL2, CXCL8, DEFB132, DSG1, DUSP4, DUSP9, DYNC1I1, EBI3, EGFR, EVL, FABP5, FBXL13, FBXL22, FBXL7, FBXO17, FBXO2, FBXO27, FGF1, FGF2, FGF20, FGF5, FGFR2, FGG, FLG2, FLNA, FN1, FPR1, FSCN1, FYN, GATA3, GBP1, GBP5, GDNF, GFRA1, GHR, GLIPR1, GRIN1, GSTP1, HBEGF, HLA-A, HLA-B, HLA-DMB, HLA-DOB, HLA-DQA1, HPSE, HRNR, ICAM1, ICAM2, ICAM5, IFIT1, IFIT2, IFIT3, IFIT5, IFITM2, IFNA1, IFNLR1, IL12B, IL12RB2, IL18, IL1A, IL1R2, IL1RAP, IL1RAPL1, IL1RL2, IL20, IL22RA1, IL22RA2, IL27, IL31RA, IL32, IL33, IL6, IL7R, IQGAP2, IRAK2, IRAK3, IRF7, ITGA4, ITGB1, ITGB2, ITGB3, KIF26A, KIF3C, KIF5A, KL, KLC3, KLHL5, KSR1, LBP, LCK, LIF, LMO7, LNX1, LTB, LYN, MAPK10, MET, METTL7A, MID1, MME, MMP2, MMP9, MRAS, MRC2, MSN, MUC13, MUC16, MUC19, MUC5B, MUCL1, MX2, MYO10, NCF2, NFASC, NFATC2, NLRP1, NRG1, NRG3, OLR1, OSMR, PDCD1LG2, PDGFRB, PGLYRP2, PIGR, PIK3AP1, PIK3CD, PIK3R3, PLA2G2A, PLAC8, PLAU, PLAUR, PLD1, PRCP, PRKCQ, PRKG2, PRL, PRLR, PROS1, PRSS3, PSMB8, PTGS2, PTPRB, PTPRN2, PTX3, PVR, PYGL, QPCT, RAB3A, RAB9B, RAC2, RAET1E, RAG1, RASAL2, RASGRP3, RET, RHOU, RIPK3, RNASEL, RNF130, RNF182, RNF217, RORC, S100A1, S100A12, S100A7, S100A7A, S100A8, S1PR1, SARM1, SERPINA3, SERPINB10, SERPINB2, SERPINB3, SERPING1, SH3KBP1, SIRPB1, SLAMF7, SLC11A1, SLC2A3, SMURF2, SOX2, SRC, STING1, TAP2, TEK, TGFA, TGFB1, TIMP1, TIMP2, TLR1, TLR2, TLR6, TNFAIP3, TNFRSF11B, TNFRSF14, TNFRSF1B, TNFRSF9, TNFSF12, TNFSF14, TNFSF15, TNFSF18, TRAT1, TREML2, TRIM10, TRIM29, TRIM3, TRIM48, TRIM9, TRPC1, TUBA4A, TUBAL3, TUBB2B, TUBB3, TUBB4A, TUBB6, ULBP3, UNC13D, VAV1, VAV3, VIM, VTN, XDH, ZBP1, ZEB1"
"328","Defective SLC9A9 causes autism 16 (AUTS16)",1,1,0.9699,"SLC9A9"
"329","Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)",1,1,0.9699,"CYP27A1"
"330","Removal of aminoterminal propeptides from gamma-carboxylated proteins",3,10,0.9699,"F7, GAS6, PROS1"
"331","PI-3K cascade-FGFR1",5,21,0.9699,"FGF1, FGF2, FGF20, FGF5, KL"
"332","Adenylate cyclase inhibitory pathway",4,14,0.9699,"ADCY1, ADCY2, ADCY5, ADCY7"
"333","Biological oxidations",34,213,0.9699,"ACSM1, AKR7A3, CYP11A1, CYP1A2, CYP24A1, CYP26A1, CYP27A1, CYP2A6, CYP2A7, CYP2E1, CYP2S1, CYP2U1, CYP4B1, CYP4F22, CYP4F8, CYP51A1, ESD, GGT1, GGT6, GLYAT, GSTA3, GSTM3, GSTM5, GSTP1, NAT1, NNMT, PTGIS, SLC26A2, SMOX, SULT1A1, SULT4A1, TPST1, UGT2B15, UGT2B17"
"334","Signaling by RAF1 mutants",9,43,0.9711,"APBB1IP, ARRB1, CAMK2A, CNKSR2, FGG, FN1, ITGB3, KSR1, SRC"
"335","Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",1,1,0.9751,"SLCO1B3"
"336","Negative regulation of FGFR2 signaling",7,34,0.9751,"FGF1, FGF2, FGF20, FGF5, FGFR2, SPRY2, SRC"
"337","Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)",1,1,0.9751,"CYP4F22"
"338","p75NTR regulates axonogenesis",3,10,0.9751,"MCF2, NGF, NGFR"
"339","ERBB2 Regulates Cell Motility",4,15,0.9751,"EGFR, HBEGF, NRG1, NRG3"
"340","CHL1 interactions",3,9,0.9751,"ITGA1, ITGB1, NRP1"
"341","Miscellaneous transport and binding events",6,26,0.9751,"ADD2, ADD3, AZGP1, DMTN, NIPAL4, PIP"
"342","Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",1,1,0.9751,"SLCO1B1"
"343","Heparan sulfate heparin (HS-GAG) metabolism",11,55,0.9751,"BGN, CSPG4, DCN, EXT1, HPSE, HS3ST1, HS3ST3B1, HS6ST3, HSPG2, SDC4, VCAN"
"344","Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",1,1,0.9751,"SLCO2A1"
"345","Endosomal Vacuolar pathway",3,11,0.9751,"CTSV, HLA-A, HLA-B"
"346","Signaling by FGFR2 amplification mutants",1,1,0.9816,"FGFR2"
"347","Signaling by FGFR2 fusions",1,1,0.9816,"FGFR2"
"348","Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)",1,1,0.9816,"CYP24A1"
"349","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2",1,1,0.9816,"CYP1A2"
"350","Ca2+ pathway",12,62,0.9816,"CAMK2A, FZD2, FZD6, GNG10, GNG11, GNG2, GNGT2, PDE6B, PRKCA, PRKG2, TCF7, WNT11"
"351","Negative regulation of activity of TFAP2 (AP-2) family transcription factors",3,10,0.9816,"KCTD15, TFAP2B, TFAP2C"
"352","Elevation of cytosolic Ca2+ levels",4,15,0.9816,"P2RX2, P2RX5, P2RX6, TRPC3"
"353","Ketone body metabolism",3,10,0.9816,"BDH1, HMGCS2, OXCT2"
"354","Defective SLC12A1 causes Bartter syndrome 1 (BS1)",1,1,0.9816,"SLC12A1"
"355","Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)",1,1,0.9816,"SLC1A1"
"356","Glucagon signaling in metabolic regulation",7,33,0.9816,"ADCY1, ADCY2, ADCY5, ADCY7, GNG10, GNG11, GNG2"
"357","Purine catabolism",4,17,0.9816,"GDA, GPX1, NT5E, XDH"
"358","Defective SLC1A3 causes episodic ataxia 6 (EA6)",1,1,0.9816,"SLC1A3"
"359","PI3K events in ERBB4 signaling",3,10,0.9816,"HBEGF, NRG1, NRG3"
"360","RUNX2 regulates chondrocyte maturation",2,5,0.9816,"GLI2, RUNX2"
"361","Defective SLC2A10 causes arterial tortuosity syndrome (ATS)",1,1,0.9816,"SLC2A10"
"362","Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",1,1,0.9816,"SLC9A6"
"363","Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)",1,1,0.9816,"CYP2U1"
"364","Sphingolipid metabolism",16,89,0.9816,"ACER1, ACER2, ALDH3B1, ARSH, ARSI, ARSL, DEGS2, FA2H, PPM1L, PRKD1, PRKD3, SGPP1, SPTLC3, SPTSSB, STS, UGT8"
"365","Reactions specific to the hybrid N-glycan synthesis pathway",1,1,0.9816,"MGAT3"
"366","Glycerophospholipid biosynthesis",22,128,0.9816,"AGPAT4, ALPI, AWAT2, BCHE, CHAT, CPNE6, ETNPPL, GPAT3, GPD1L, OSBPL5, PCYT1B, PLA2G2A, PLA2G2E, PLA2G4A, PLA2G4F, PLA2G5, PLA2R1, PLAAT2, PLB1, PLD1, SLC44A4, STARD10"
"367","Hyaluronan biosynthesis and export",2,5,0.9816,"CEMIP, HAS2"
"368","Mineralocorticoid biosynthesis",2,6,0.9816,"CGA, HSD3B1"
"369","Caspase activation via Dependence Receptors in the absence of ligand",3,10,0.9816,"DAPK1, DCC, UNC5A"
"370","Intrinsic Pathway of Fibrin Clot Formation",5,22,0.9816,"KLKB1, PRCP, PROS1, SERPINE2, SERPING1"
"371","A tetrasaccharide linker sequence is required for GAG synthesis",6,26,0.9816,"BGN, CSPG4, DCN, HSPG2, SDC4, VCAN"
"372","Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",1,1,0.9816,"SLC4A4"
"373","CTLA4 inhibitory signaling",5,21,0.9816,"AKT3, FYN, LCK, LYN, SRC"
"374","Defective SLC26A2 causes chondrodysplasias",1,1,0.9816,"SLC26A2"
"375","Signaling by KIT in disease",5,20,0.9816,"FYN, LCK, LYN, PIK3R3, SRC"
"376","Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",5,20,0.9816,"FYN, LCK, LYN, PIK3R3, SRC"
"377","Defective ABCA12 causes ARCI4B",1,1,0.9816,"ABCA12"
"378","Pyrimidine salvage",3,11,0.9816,"CDA, PUDP, UPP1"
"379","Signaling by WNT",46,298,0.9816,"AXIN2, CAMK2A, CAV1, DACT1, DKK1, FRAT1, FZD2, FZD6, FZD7, GNG10, GNG11, GNG2, GNGT2, H2AJ, HECW1, LGR5, PDE6B, PIP5K1B, PRICKLE1, PRKCA, PRKG2, PSMB8, PYGO1, RAC2, ROR1, ROR2, RSPO3, SFRP1, SMURF2, SOST, SOX2, SOX3, SOX7, TCF7, TLE4, VANGL2, WIF1, WLS, WNT10A, WNT11, WNT16, WNT3, WNT4, WNT5B, WNT6, WNT7A"
"380","NTRK2 activates RAC1",2,5,0.9825,"BDNF, FYN"
"381","DAG and IP3 signaling",9,43,0.9868,"ADCY1, ADCY2, ADCY5, ADCY7, CAMK2A, CAMK4, PDE1A, PDE1C, PRKCA"
"382","Ion transport by P-type ATPases",11,57,0.9868,"ATP10D, ATP13A4, ATP13A5, ATP2A3, ATP2C2, ATP8B3, CAMK2A, FXYD1, FXYD3, FXYD6, FXYD7"
"383","Vasopressin-like receptors",2,6,0.9925,"AVPR1A, AVPR2"
